Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares (NQ:LSE)

4.500 +0.210 (+4.90%)

Streaming Delayed Price Updated: 1:54 PM EDT, Jun 30, 2026 Add to My Watchlist

Price and Volume

Volume	5,236
Open	4.155
Bid (Size)	4.390 (100)
Ask (Size)	4.600 (200)
Prev. Close	4.290
Today's Range	4.155 - 4.990
52wk Range	3.200 - 6.980
Shares Outstanding	17,025,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

HUTCHMED to Announce 2026 Half-Year Financial Results

Today 4:30 EDT

From HUTCHMED (China) Limited

Via GlobeNewswire

Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing

June 26, 2026

From Virtual Investor Conferences

Via GlobeNewswire

Performance

YTD	+5.4%	+5.4%
1 Month	-0.4%	-0.4%
3 Month	-5.1%	-5.1%
6 Month	+5.0%	+5.0%
1 Year	-20.4%	-20.4%

More News

HUTCHMED Highlights Pivotal Phase II Data for Fanregratinib in Intrahepatic Cholangiocarcinoma Presented at ESMO Gastrointestinal Cancers Congress 2026

June 24, 2026

From HUTCHMED (China) Limited

Via GlobeNewswire

Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th

June 23, 2026

From Virtual Investor Conferences

Via GlobeNewswire

Leishen Energy Named as the No. 1 Bid Winner for Surface Control Integrated Devices with a Sinopec Oilfield

June 16, 2026

From Leishen Energy Holding Co., Ltd.

Via GlobeNewswire

HUTCHMED Highlights Sovleplenib ESLIM-02 Phase III Data in Warm Antibody Autoimmune Hemolytic Anemia Presented at EHA 2026 Congress

June 11, 2026

From HUTCHMED (China) Limited

Via GlobeNewswire

Avacta presents updated clinical data showing encouraging early efficacy signals for AVA6000 in salivary gland cancers at ASCO 2026

June 01, 2026

From Avacta Group PLC

Via GlobeNewswire

PPHC to Participate in Stifel’s Ninth Annual Boston Cross Sector 1x1 Conference

May 29, 2026

From Public Policy Holding Company, Inc.

Via GlobeNewswire

HUTCHMED Highlights Clinical Data to be Presented at the 2026 ASCO Annual Meeting

May 21, 2026

From HUTCHMED (China) Limited

Via GlobeNewswire

HUTCHMED and Innovent Jointly Announce NMPA Approval for ELUNATE® (Fruquintinib) in Combination with TYVYT® (Sintilimab Injection) for the Treatment of Patients with Locally Advanced or Metastatic Renal Cell Carcinoma

May 21, 2026

From HUTCHMED (China) Limited

Via GlobeNewswire

Alpha FMC Appoints Charles Cummins as Senior Partner in North American Wealth Management Team

May 20, 2026

From Alpha FMC

Via GlobeNewswire

Metals One to Present at the Precious Metals & Critical Minerals Hybrid Investor Conference on May 21st

May 20, 2026

From Virtual Investor Conferences

Via GlobeNewswire

Unaudited Preliminary Results for the Year Ended December 31, 2025

May 19, 2026

From Avacta Group PLC

Via GlobeNewswire

Amaroq Ltd to Present at the Precious Metals & Critical Minerals Hybrid Investor Conference on May 21st

May 18, 2026

From Virtual Investor Conferences

Via GlobeNewswire

Public Policy Holding Company, Inc. Announces Q1 2026 Financial Results

May 12, 2026

From Public Policy Holding Company, Inc.

Via GlobeNewswire

Avacta presents new comparisons of pre|CISION® payload release vs approved ADCs and AVA6207 dual payload delivery at Science Day 2026

May 06, 2026

From Avacta Group PLC

Via GlobeNewswire

Galantas Gold to Present at the Precious Metals & Critical Minerals Virtual Investor Conference May 6th 2026

May 05, 2026

From Virtual Investor Conferences

Via GlobeNewswire

PPHC Expands MultiState Associates' Stakeholder Engagement Capabilities

May 01, 2026

From Public Policy Holding Company, Inc.

Via GlobeNewswire

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing

April 29, 2026

From Virtual Investor Conferences

Via GlobeNewswire

Concordant Launches Regulatory and Political Due Diligence Practice for Investors and Deal Teams

April 29, 2026

From Public Policy Holding Company, Inc.

Via GlobeNewswire

HUTCHMED Announces NDA Acceptance in China with Priority Review Status and Breakthrough Designation for Sovleplenib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

April 29, 2026

From HUTCHMED (China) Limited

Via GlobeNewswire

PPHC to Report First Quarter 2026 Financial Results on May 12, 2026

April 28, 2026

From Public Policy Holding Company, Inc.

Via GlobeNewswire

Scancell receives FDA Fast Track Designation for iSCIB1+ in advanced melanoma and provides data update from its SCOPE Phase 2 study

April 28, 2026

From Scancell Holdings Plc

Via GlobeNewswire

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on April 28, 2026

April 23, 2026

From Virtual Investor Conferences

Via GlobeNewswire

Avacta data at AACR 2026 underline favorable profile of AVA6103 and advantages of pre|CISION® delivery platform

April 21, 2026

From Avacta Group PLC

Via GlobeNewswire

Frequently Asked Questions

Is Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares publicly traded?

Yes, Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares is publicly traded.

What exchange does Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares trade on?

Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares?

The ticker symbol for Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares is LSE on the Nasdaq Stock Market

What is the current price of Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares?

The current price of Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares is 4.500

When was Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares last traded?

The last trade of Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares was at 06/30/26 01:54 PM ET

What is the market capitalization of Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares?

The market capitalization of Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares is 76.61M

How many shares of Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares are outstanding?

Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares has 77M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.